About
Numares develops advanced biomarker diagnostic tests using nuclear magnetic resonance spectroscopy combined with machine learning to diagnose and monitor diseases related to metabolic dysfunction, including cardiovascular, kidney, and liver conditions.
Explore Numares's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.